600664 哈药股份
已收盘 04-29 15:00:00
资讯
新帖
简况
哈药股份（600664）股东哈药集团有限公司质押8000万股，占总股本3.18%
证券之星 · 04-27 18:44
哈药股份（600664）股东哈药集团有限公司质押8000万股，占总股本3.18%
每周股票复盘：哈药股份（600664）2025年净利降42.5%
证券之星 · 04-26
每周股票复盘：哈药股份（600664）2025年净利降42.5%
哈药股份（600664）2026年一季报简析：增收不增利
证券之星 · 04-24
哈药股份（600664）2026年一季报简析：增收不增利
哈药股份(600664)3月31日股东户数9.33万户，较上期减少1.85%
证券之星 · 04-22
哈药股份(600664)3月31日股东户数9.33万户，较上期减少1.85%
股市必读：哈药股份（600664）4月17日收盘跌5.23%，主力净流入132.36万元
证券之星 · 04-20
股市必读：哈药股份（600664）4月17日收盘跌5.23%，主力净流入132.36万元
每周股票复盘：哈药股份（600664）两日涨幅偏离值超20%
证券之星 · 04-19
每周股票复盘：哈药股份（600664）两日涨幅偏离值超20%
哈药股份（600664）披露股票交易异常波动公告，4月16日股价下跌0.9%
证券之星 · 04-16
哈药股份（600664）披露股票交易异常波动公告，4月16日股价下跌0.9%
A股收评 | 沪指微涨0.01% 伊朗局势突发！全球午后突变
智通财经网 · 04-15
A股收评 | 沪指微涨0.01% 伊朗局势突发！全球午后突变
4月14日哈药股份（600664）龙虎榜数据：北向资金净买入1732.47万元
证券之星 · 04-14
4月14日哈药股份（600664）龙虎榜数据：北向资金净买入1732.47万元
股市必读：哈药股份（600664）3月23日收盘跌6.1%，主力净流出3038.32万元
证券之星 · 03-24
股市必读：哈药股份（600664）3月23日收盘跌6.1%，主力净流出3038.32万元
每周股票复盘：哈药股份（600664）内部管理机构调整
证券之星 · 03-15
每周股票复盘：哈药股份（600664）内部管理机构调整
哈药股份（600664）披露董事会关于内部管理机构调整的议案，3月9日股价上涨4.01%
证券之星 · 03-09
哈药股份（600664）披露董事会关于内部管理机构调整的议案，3月9日股价上涨4.01%
哈药股份(600664.SH)：注射用头孢噻肟钠通过仿制药一致性评价
智通财经 · 02-10
哈药股份(600664.SH)：注射用头孢噻肟钠通过仿制药一致性评价
【私募调研记录】中金银海调研哈药股份
证券之星 · 02-09
【私募调研记录】中金银海调研哈药股份
每周股票复盘：哈药股份（600664）Q3净利降35.35%，GNC中国拟降本增效
证券之星 · 02-08
每周股票复盘：哈药股份（600664）Q3净利降35.35%，GNC中国拟降本增效
哈药股份：2月5日接受机构调研，中金银海(香港)基金有限公司、中天汇鑫(北京)投资基金管理有限公司等多家机构参与
证券之星 · 02-06
哈药股份：2月5日接受机构调研，中金银海(香港)基金有限公司、中天汇鑫(北京)投资基金管理有限公司等多家机构参与
哈药股份：所属企业获得化学原料药上市申请批准通知书
新京报 · 02-05
哈药股份：所属企业获得化学原料药上市申请批准通知书
哈药股份(600664.SH)所属企业药品通过一致性评价
智通财经 · 02-04
哈药股份(600664.SH)所属企业药品通过一致性评价
哈药股份(600664.SH)：蛋白琥珀酸铁口服溶液获得药品注册证书
智通财经 · 02-02
哈药股份(600664.SH)：蛋白琥珀酸铁口服溶液获得药品注册证书
每周股票复盘：哈药股份（600664）2026年日常关联交易预计5,192.90万元
证券之星 · 02-01
每周股票复盘：哈药股份（600664）2026年日常关联交易预计5,192.90万元
加载更多
公司概况
公司名称：
哈药集团股份有限公司
所属行业：
医药制造业
上市日期：
1993-06-29
主营业务：
哈药集团股份有限公司的主营业务是医药研发与制造、批发与零售业务。公司的主要产品是葡萄糖酸锌口服溶液、哈药牌钙铁锌口服液、复方葡萄糖酸钙口服溶液、人促红素注射液、阿莫西林胶囊、双黄连口服液、注射用青霉素钠、祛风骨痛凝胶膏、拉西地平片、小儿氨酚黄那敏颗粒。报告期内，人民同泰物流服务能力获得行业广泛认可，荣获中国物流与采购联合会医药物流与供应链分会颁发的“2024年度医药冷链仓储能力重点调研企业”、“《药品冷链物流运作规范》国家标准示范企业”；药链圈认证中心“2024-2025年医药物流配送优秀企业”、“2024-2025年度医药冷链最佳物流中心（基地）”、“2024-2025年度药品、医疗器械供应链最佳服务商”及“2024-2025年度药品数智物流技术服务推荐品牌”等荣誉。
发行价格：
1.00
{"stockData":{"symbol":"600664","market":"SH","secType":"STK","nameCN":"哈药股份","latestPrice":3.68,"timestamp":1777446000000,"preClose":3.69,"halted":0,"volume":96110898,"delay":0,"changeRate":-0.0027,"floatShares":2519000000,"shares":2519000000,"eps":0.1231,"marketStatus":"已收盘","change":-0.01,"latestTime":"04-29 15:00:00","open":3.65,"high":3.69,"low":3.58,"amount":352000000,"amplitude":0.0298,"askPrice":3.68,"askSize":11977,"bidPrice":3.67,"bidSize":9905,"shortable":0,"etf":0,"ttmEps":0.1231,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777512600000},"marketStatusCode":5,"adr":0,"adjPreClose":3.69,"symbolType":"stock","openAndCloseTimeList":[[1777426200000,1777433400000],[1777438800000,1777446000000]],"highLimit":4.06,"lowLimit":3.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2518509876,"isCdr":false,"pbRate":1.58,"roa":"--","peRate":29.894395,"roe":"2.79%","epsLYR":0.14,"committee":-0.114611,"marketValue":9268000000,"turnoverRate":0.0382,"status":1,"floatMarketCap":9268000000},"requestUrl":"/m/hq/s/600664","defaultTab":"news","newsList":[{"id":"2630360059","title":"哈药股份（600664）股东哈药集团有限公司质押8000万股，占总股本3.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630360059","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630360059?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:44","pubTimestamp":1777286651,"startTime":"0","endTime":"0","summary":"证券之星消息，哈药股份4月27日公开信息显示，股东哈药集团有限公司向东亚银行(中国)有限公司哈尔滨分行合计质押8000.0万股，占总股本3.18%。质押详情见下表：截止本公告日，股东哈药集团有限公司已累计质押股份5.24亿股，占其持股总数的44.65%。哈药股份主营业务：公司专注于医药健康产业,主要从事医药研发与制造、批发与零售业务,是集医药研发、制造、销售于一体的国内大型高新技术医药企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700035276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600664","BK0188","BK0012","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630809001","title":"每周股票复盘：哈药股份（600664）2025年净利降42.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630809001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630809001?lang=zh_cn&edition=full","pubTime":"2026-04-26 01:49","pubTimestamp":1777139353,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，哈药股份报收于3.7元，较上周的4.17元下跌11.27%。本周，哈药股份4月20日盘中最高价报4.34元。业绩披露要点财务报告哈药股份2025年实现主营收入159.64亿元，同比下降1.31%；归母净利润3.62亿元，同比下降42.5%；扣非净利润3.08亿元，同比下降47.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600000553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0188","600664","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629477288","title":"哈药股份（600664）2026年一季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2629477288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629477288?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:11","pubTimestamp":1777039894,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期哈药股份发布2026年一季报。根据财报显示，哈药股份增收不增利。截至本报告期末，公司营业总收入41.75亿元，同比上升0.02%，归母净利润1.61亿元，同比下降24.33%。本次财报公布的各项数据指标表现一般。答：公司 2025 年前三季度利润总额为 48,103.91 万元，同比下降32.31%；归属于上市公司股东的净利润为 32,859.45 万元，同比下降35.35%。同时，市场非药类制剂以强势宣传推广手段大力抢占市场份额。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400064647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600664","BK0012","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629019463","title":"哈药股份(600664)3月31日股东户数9.33万户，较上期减少1.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629019463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629019463?lang=zh_cn&edition=full","pubTime":"2026-04-22 17:23","pubTimestamp":1776849790,"startTime":"0","endTime":"0","summary":"证券之星消息，近日哈药股份披露，截至2026年3月31日公司股东户数为9.33万户，较12月31日减少1757.0户，减幅为1.85%。在化学制药行业个股中，哈药股份股东户数高于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.49万户。从股价来看，2025年12月31日至2026年3月31日，哈药股份区间涨幅为2.03%，在此期间股东户数减少1757.0户，减幅为1.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200040135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","600664","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628779961","title":"股市必读：哈药股份（600664）4月17日收盘跌5.23%，主力净流入132.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628779961","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628779961?lang=zh_cn&edition=full","pubTime":"2026-04-20 06:20","pubTimestamp":1776637221,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，哈药股份报收于4.17元，下跌5.23%，换手率16.01%，成交量403.16万手，成交额17.05亿元。来自交易信息汇总：该股已连续2日下跌，前10个交易日主力资金累计净流出2.2亿元，期间股价累计上涨8.29%。交易信息汇总股价提醒4月17日哈药股份收盘报4.17元，跌5.23%，当日成交4.03亿元。资金流向4月17日主力资金净流入132.36万元，占总成交额0.08%；游资资金净流出551.84万元，占总成交额0.32%；散户资金净流入419.48万元，占总成交额0.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000001708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600664","BK0188","BK0012","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628875118","title":"每周股票复盘：哈药股份（600664）两日涨幅偏离值超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628875118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628875118?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:55","pubTimestamp":1776542109,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，哈药股份报收于4.17元，较上周的3.76元上涨10.9%。本周关注点来自交易信息汇总：哈药股份因三日涨幅偏离值达20%两次登上龙虎榜。交易信息汇总沪深交易所2026年4月15日公布交易公开信息显示，哈药股份因非ST、*ST和S证券连续三个交易日内收盘价格涨幅偏离值累计达到20%登上龙虎榜，为近5个交易日内第2次上榜。在本次股价异动期间，公司未买卖哈药股份股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600664","BK0239","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627055293","title":"哈药股份（600664）披露股票交易异常波动公告，4月16日股价下跌0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627055293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627055293?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:07","pubTimestamp":1776330469,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，哈药股份报收于4.4元，较前一交易日下跌0.9%，最新总市值为110.81亿元。该股当日开盘4.7元，最高4.88元，最低4.4元，成交额达28.33亿元，换手率为24.21%。哈药集团股份有限公司于近日发布《股票交易异常波动公告》。公告显示，公司股票于2026年4月14日、2026年4月15日连续2个交易日内日收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动情形。公司控股股东亦确认不存在影响股价的重大事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600030235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0012","600664","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627062554","title":"A股收评 | 沪指微涨0.01% 伊朗局势突发！全球午后突变","url":"https://stock-news.laohu8.com/highlight/detail?id=2627062554","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627062554?lang=zh_cn&edition=full","pubTime":"2026-04-15 15:08","pubTimestamp":1776236903,"startTime":"0","endTime":"0","summary":"截至收盘，沪指涨0.01%报4027.21点，成交10289亿元；深成指跌0.97%报14498.45点，成交13726亿元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260415/20260415150338_75294.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260415/20260415150338_75294.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["000070","515890","510300","002808","688353","512880","600918","002361","399006","000688.SH","000905.SH","512510","510880","001208","000300.SH","002083","000919","688166","002788","159967","399001","600488","600664","301292","688313","002926","000001","300502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627411074","title":"4月14日哈药股份（600664）龙虎榜数据：北向资金净买入1732.47万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627411074","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627411074?lang=zh_cn&edition=full","pubTime":"2026-04-14 17:25","pubTimestamp":1776158724,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年4月14日公布的交易公开信息显示，哈药股份因有价格涨跌幅限制的日收盘价格涨幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年4月14日收盘，哈药股份报收于4.04元，上涨10.08%，涨停，换手率10.19%，成交量256.69万手，成交额9.92亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净买入1732.47万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400028839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0012","600664","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621083351","title":"股市必读：哈药股份（600664）3月23日收盘跌6.1%，主力净流出3038.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621083351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621083351?lang=zh_cn&edition=full","pubTime":"2026-03-24 01:17","pubTimestamp":1774286263,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，哈药股份报收于3.23元，下跌6.1%，换手率1.64%，成交量41.32万手，成交额1.36亿元。来自交易信息汇总：该股已连续4日下跌，前10个交易日主力资金累计净流出4880.05万元，股价累计下跌9.26%。交易信息汇总股价提醒3月23日哈药股份收盘报3.23元，跌6.1%，当日成交4131.61万元。资金流向3月23日主力资金净流出3038.32万元，占总成交额22.37%；游资资金净流入899.53万元，占总成交额6.62%；散户资金净流入2138.79万元，占总成交额15.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600664","BK0012","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619120270","title":"每周股票复盘：哈药股份（600664）内部管理机构调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2619120270","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619120270?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:20","pubTimestamp":1773512425,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，哈药股份报收于3.59元，较上周的3.49元上涨2.87%。本周，哈药股份3月9日盘中最高价报3.67元。哈药股份当前最新总市值90.41亿元，在化学制药板块市值排名60/150，在两市A股市值排名2217/5190。本周关注点公司公告汇总：哈药股份将审计监察部分拆为审计部和市场监察部。公司公告汇总哈药集团股份有限公司于2026年3月9日召开十届二十四次董事会，审议通过《关于公司部分内部管理机构调整的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","600664","BK0028","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618624786","title":"哈药股份（600664）披露董事会关于内部管理机构调整的议案，3月9日股价上涨4.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618624786","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618624786?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:08","pubTimestamp":1773065296,"startTime":"0","endTime":"0","summary":"截至2026年3月9日收盘，哈药股份报收于3.63元，较前一交易日上涨4.01%，最新总市值为91.42亿元。该股当日开盘3.5元，最高3.67元，最低3.48元，成交额达4.38亿元，换手率为4.82%。近日，哈药集团股份有限公司召开十届二十四次董事会，审议通过《关于公司部分内部管理机构调整的议案》。审计部承接原部门的审计职能及人员，市场监察部承接监察职能及人员。会议表决结果为同意9票，反对0票，弃权0票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900034966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600664","BK0012","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610961445","title":"哈药股份(600664.SH)：注射用头孢噻肟钠通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2610961445","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610961445?lang=zh_cn&edition=full","pubTime":"2026-02-10 15:50","pubTimestamp":1770709847,"startTime":"0","endTime":"0","summary":"智通财经APP讯，哈药股份(600664.SH)发布公告，近日，公司所属企业哈药集团制药总厂(简称“哈药总厂”)收到国家药品监督管理局颁发的关于注射用头孢噻肟钠的《药品补充申请批准通知书》【1.0g(按C16H17N5O7S2计)，通知书编号：2026B00713;0.5g(按C16H17N5O7S2计)，通知书编号：2026B00715】，以上药品通过仿制药质量和疗效一致性评价。注射用头孢噻肟钠适用于敏感细菌所致的下呼吸道感染、泌尿生殖道感染、妇科感染、菌血症/败血症、皮肤及皮肤软组织感染、腹腔感染、骨和关节感染、中枢神经系统感染。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"哈药股份(600664.SH)：注射用头孢噻肟钠通过仿制药一致性评价","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0028","BK0188","BK0012","600664"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610505238","title":"【私募调研记录】中金银海调研哈药股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2610505238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610505238?lang=zh_cn&edition=full","pubTime":"2026-02-09 08:01","pubTimestamp":1770595264,"startTime":"0","endTime":"0","summary":"根据市场公开信息及2月6日披露的机构调研信息，知名私募中金银海近期对1家上市公司进行了调研，相关名单如下：1）哈药股份 调研纪要：公司2025年前三季度利润总额为48,103.91万元，同比下降32.31%；归母净利润为32,859.45万元，同比下降35.35%。GNC中国聚焦电商全渠道建设，优化费用管理，推进降本增效。中金银海专注于二级市场的证券投资，核心团队成员为何军民等业内资深专业人士，力争成为中国领先的私募证券基金管理公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026020900001200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0239","BK0188","600664"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609178526","title":"每周股票复盘：哈药股份（600664）Q3净利降35.35%，GNC中国拟降本增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2609178526","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609178526?lang=zh_cn&edition=full","pubTime":"2026-02-08 03:13","pubTimestamp":1770491590,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，哈药股份报收于3.52元，较上周的3.52元上涨0.0%。本周，哈药股份2月6日盘中最高价报3.56元。来自机构调研要点：GNC中国将聚焦电商全渠道建设，并推进降本增效以降低销售费用投入。业绩披露要点公司2025年前三季度利润总额为48,103.91万元，同比下降32.31%；归属于上市公司股东的净利润为32,859.45万元，同比下降35.35%。截至目前，国内共有11家企业该原料药登记状态为“A”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0188","600664","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609562672","title":"哈药股份：2月5日接受机构调研，中金银海(香港)基金有限公司、中天汇鑫(北京)投资基金管理有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2609562672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609562672?lang=zh_cn&edition=full","pubTime":"2026-02-06 19:01","pubTimestamp":1770375702,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年2月6日哈药股份发布公告称公司于2026年2月5日接受机构调研，中金银海(香港)基金有限公司、中天汇鑫(北京)投资基金管理有限公司、上海汇正财经顾问有限公司参与。三是紧盯市场动态，强化品牌价值，促进 GNC 中国业务合规、高质量发展。子公司已分别于 2023 年和 2024 年连续两年向母公司累计分红 4.03 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600034275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","600664","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609532268","title":"哈药股份：所属企业获得化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2609532268","media":"新京报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609532268?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:22","pubTimestamp":1770279720,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯 2月5日，哈药股份公告，所属企业哈药集团三精明水药业有限公司收到国家药品监督管理局颁发的关于蛋白琥珀酸铁的《化学原料药上市申请批准通知书》【编号：2026YS00100】。蛋白琥珀酸铁是一种有机铁化合物，本品获得化学原料药上市申请批准通知书，表明该原料药已符合国家相关药品审评技术标准。国家药品监督管理局药品审评中心网站显示，截至本公告日，国内蛋白琥珀酸铁原料药登记状态为“A”的企业共有11家，包含哈药集团三精明水药业有限公司、济川药业集团有限公司等。","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2026/01/12/5674876761498789488.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/01/12/5674876761498789488.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1770277199129176.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1770277199129176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0239","600664","BK0012","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608353053","title":"哈药股份(600664.SH)所属企业药品通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2608353053","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608353053?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:46","pubTimestamp":1770191173,"startTime":"0","endTime":"0","summary":"智通财经APP讯，哈药股份(600664.SH)公告，公司所属企业哈药集团制药总厂(简称“哈药总厂”)收到国家药品监督管理局颁发的关于注射用头孢哌酮钠舒巴坦钠(1:1)和注射用头孢哌酮钠舒巴坦钠(2:1)的《药品补充申请批准通知书》【编号：2026B00587、2026B00592、2026B00590、2026B00591】，以上两个药品共4个规格通过仿制药质量和疗效一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0012","600664","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608569328","title":"哈药股份(600664.SH)：蛋白琥珀酸铁口服溶液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2608569328","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608569328?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:02","pubTimestamp":1770019330,"startTime":"0","endTime":"0","summary":"智通财经APP讯，哈药股份(600664.SH)发布公告，近日，公司所属企业哈药集团中药二厂(简称“中药二厂”)收到国家药品监督管理局颁发的关于蛋白琥珀酸铁口服溶液的《药品注册证书》【编号：2026S00300】，本品获得批准注册。蛋白琥珀酸铁口服溶液为非处方药，用于治疗缺铁性贫血，包括由于铁摄入量不足或吸收障碍、慢性失血以及妊娠与哺乳期引起的缺铁性贫血。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"哈药股份(600664.SH)：蛋白琥珀酸铁口服溶液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","600664","BK0012","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608607068","title":"每周股票复盘：哈药股份（600664）2026年日常关联交易预计5,192.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608607068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608607068?lang=zh_cn&edition=full","pubTime":"2026-02-01 04:12","pubTimestamp":1769890334,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：哈药股份2026年度日常关联交易预计总额为5,192.90万元。哈药集团股份有限公司于2026年1月26日召开十届二十三次董事会，审议通过《关于公司2026年度日常关联交易预计的议案》，关联董事回避表决。2026年预计日常关联交易总额为5,192.90万元，主要包括向哈药集团生物疫苗有限公司等关联方销售产品、提供劳务，向GNC HOLDINGS, LLC采购产品及支付特许权使用费，以及向黑龙江省哈药公益基金会捐赠。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","600664","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777502175232,"stockEarnings":[{"period":"1week","weight":-0.0636},{"period":"1month","weight":0.0667},{"period":"3month","weight":0.0395},{"period":"6month","weight":0.0055},{"period":"1year","weight":0.0082},{"period":"ytd","weight":0.0667}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.047},{"period":"3month","weight":-0.0121},{"period":"6month","weight":0.0386},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"哈药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"93273人(较上一季度减少1.85%)","perCapita":"27001股","listingDate":"1993-06-29","address":"黑龙江省哈尔滨市呼兰区利民开发区利民西四大街68号","registeredCapital":"251850万元","survey":" 哈药集团股份有限公司的主营业务是医药研发与制造、批发与零售业务。公司的主要产品是葡萄糖酸锌口服溶液、哈药牌钙铁锌口服液、复方葡萄糖酸钙口服溶液、人促红素注射液、阿莫西林胶囊、双黄连口服液、注射用青霉素钠、祛风骨痛凝胶膏、拉西地平片、小儿氨酚黄那敏颗粒。报告期内，人民同泰物流服务能力获得行业广泛认可，荣获中国物流与采购联合会医药物流与供应链分会颁发的“2024年度医药冷链仓储能力重点调研企业”、“《药品冷链物流运作规范》国家标准示范企业”；药链圈认证中心“2024-2025年医药物流配送优秀企业”、“2024-2025年度医药冷链最佳物流中心（基地）”、“2024-2025年度药品、医疗器械供应链最佳服务商”及“2024-2025年度药品数智物流技术服务推荐品牌”等荣誉。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"哈药股份(600664)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供哈药股份(600664)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"哈药股份,600664,哈药股份股票,哈药股份股票老虎,哈药股份股票老虎国际,哈药股份行情,哈药股份股票行情,哈药股份股价,哈药股份股市,哈药股份股票价格,哈药股份股票交易,哈药股份股票购买,哈药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"哈药股份(600664)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供哈药股份(600664)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}